Skip to main content
Premium Trial:

Request an Annual Quote

Lifebit Biotech Closes $60M Series B Funding Round

NEW YORK – Lifebit Biotech said this week that it has closed a Series B funding round worth $60 million.

Tiger Global Management led the round, with participation from previous investors Eurazeo, Pentech Ventures, and Beacon Capital. 

London-based Lifebit is a biomedical software firm that makes CloudOS, a cloud-native, federated genomics operating system for precision medicine. CloudOS functions as a managed service of individual clouds or high-performance computing centers to support analysis of bioinformatics data across sites and institutions.

In a statement, Lifebit CEO Maria Chatzou Dunford said that the company would use the new funding to expand its global presence and expand its workforce.

"We are confident that Lifebit's innovative … software solutions, paired with their customer-first approach, will drive rapid global adoption and accelerate breakthroughs in precision medicine," added John Curtius, partner at Tiger Global.

Lifebit closed a £6 million ($8.1 million) Series A funding round in April 2020.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.